TREDJE AP-FONDEN – Eli Lilly and Company Transaction History
TREDJE AP-FONDEN portfolio value:
$28.59M
portfolio value
TREDJE AP-FONDEN quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -24.40% | -28.53K shares | -9.33M | $323.35 | 88.43K |
| Q2 2022 | share | Increase | +3.54% | 4K shares | 5.57M | $324.23 | 116.96K |
| Q1 2022 | share | Increase | +17.10% | 16.5K shares | 5.70M | $286.37 | 112.96K |
| Q4 2021 | share | Decrease | -6.81% | -7.05K shares | 2.72M | $277.25 | 96.46K |
| Q3 2021 | share | Increase | 0.00% | 103.51K shares | 23.91M | $230.3 | 103.51K |
| Q2 2021 | share | Decrease | -100.00% | -273.51K shares | -51.09M | $228.04 | 0 |
| Q1 2021 | share | Increase | +45.09% | 85K shares | 19.26M | $184.81 | 273.51K |
| Q4 2020 | share | Decrease | -24.14% | -60K shares | -4.95M | $166.32 | 188.51K |
| Q3 2020 | share | Decrease | -34.34% | -130K shares | -25.36M | $145.05 | 248.51K |
| Q2 2020 | share | Increase | +198.93% | 251.89K shares | 44.58M | $160.1 | 378.51K |
| Q1 2020 | share | Increase | +21.50% | 22.40K shares | 3.86M | $134.64 | 126.62K |
| Q4 2019 | share | Decrease | -24.60% | -34K shares | -1.75M | $126.91 | 104.21K |
| Q3 2019 | share | Increase | +0.48% | 664 shares | 217K | $107.36 | 138.21K |
| Q2 2019 | share | Increase | +0.67% | 916 shares | -2.49M | $105.74 | 137.55K |
| Q1 2019 | share | Decrease | -2.28% | -3.19K shares | 1.54M | $123.17 | 136.63K |
| Q4 2018 | share | Decrease | -28.14% | -54.75K shares | -4.69M | $109.26 | 139.82K |
| Q3 2018 | share | Decrease | -25.52% | -66.65K shares | -1.41M | $100.8 | 194.57K |
| Q2 2018 | share | Increase | +29.24% | 59.10K shares | 6.65M | $79.72 | 261.23K |
| Q1 2018 | share | Increase | +6.20% | 11.79K shares | -437K | $71.78 | 202.13K |
| Q4 2017 | share | Increase | +5.39% | 9.74K shares | 628K | $77.79 | 190.33K |
| Q3 2017 | share | Decrease | -0.95% | -1.73K shares | 442K | $78.29 | 180.59K |
| Q2 2017 | share | Increase | +2.68% | 4.76K shares | 70K | $74.85 | 182.33K |
| Q1 2017 | share | Decrease | -3.02% | -5.52K shares | 1.46M | $76 | 177.57K |
| Q4 2016 | share | Increase | +2.99% | 5.31K shares | -802K | $66.02 | 183.09K |
| Q3 2016 | share | Decrease | -7.91% | -15.26K shares | -933K | $71.57 | 177.77K |
| Q2 2016 | share | Decrease | -2.40% | -4.74K shares | 7K | $69.79 | 193.04K |
| Q1 2016 | share | Increase | +18.57% | 30.97K shares | 1.13M | $63.39 | 197.79K |